Skip to main navigation Skip to search Skip to main content

Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

  • SURMOUNT-2 investigators

Research output: Contribution to journal › Article › peer-review

614   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases